We are live on
!
Find out more
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
16 hedge funds and large institutions have $2.29M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$381K | |
| 2 | +$177K | |
| 3 | +$177K | |
| 4 |
RIA
Realta Investment Advisors
Wilmington,
Delaware
|
+$8.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.64K |
Top Sellers
| 1 | -$539K | |
| 2 | -$115K | |
| 3 | -$21.2K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$15K |
| 5 |
BBPWM
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
|
-$10.7K |